glp-1 kidney disease news drugs calm inflammation beyond diabetes and weight loss GLP-1 receptor agonists in patients

There is a real sense now of a rapid expansion in the area of novel medications in the area of obesity, says Hannah Beba, pharmacist and clinical lead for obesity at West Yorkshire Integrated Care System

Stay ahead in 2025: Discover whats on the horizon for GLP-1 compounding as we navigate evolving FDA guidelines and state Boards of Pharmacy regulations

The Unanswered Questions What we still dont know: Long-term effects beyond 2-3 years: These drugs havent been widely used long enough to know 10-year, 20-year consequences Why some patients get severely injured while others dont: Is it genetic

In high-fat diet (HFD) and STZ-induced diabetic mice, Diabogel effectively reduced blood glucose, preserved body weight, improved insulin expression, and restored islet function by modulating macrophage phenotype and NF-B signaling [129]

Anesthesiology 2017;126(3):376393

With the boom of telehealth we saw more of an auditionless process for getting access to the GLP-1s